GSC
NVO

Ground Swell Capital’s Novo Nordisk NVO Stock Holding History

Ground Swell Capital’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-3,164
Closed -$377K – 228
2024
Q3 		$377K Buy
+3,164
New +$422K 0.33% 43
2014
Q3 		$10K Buy
+418
New +$9.62K 0.02% 972

Other funds holding NVO

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
GQG Partners
GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Koshinski Asset Management
Koshinski Asset Management Decatur, Illinois $1.6B AUM 20.7% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Ground Swell Capital's NVO Position: Q4 2024 in Review

Ground Swell Capital sold out of Novo Nordisk (NVO) in Q4 2024, closing a stake of 3,164 shares — an estimated $377K sold.

Ground Swell Capital first reported a position in NVO in Q3 2014 and held it in 2 quarters. The position peaked at $377K in Q3 2024. 1,663 funds tracked by Wall St. Rank hold NVO as of Q4 2024.

  • Ground Swell Capital reported no remaining Novo Nordisk position as of Q4 2024 after selling out during the quarter.
  • Ground Swell Capital sold 3,164 Novo Nordisk shares in Q4 2024, an estimated $377K.
  • Ground Swell Capital first reported a position in Novo Nordisk in Q3 2014 and held it in 2 quarters.
  • Ground Swell Capital's Novo Nordisk position peaked at $377K in Q3 2024.
  • 1,663 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2024.

Based on Ground Swell Capital's 13F filing for Q4 2024, filed 14 Feb 2025.